Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Scientific Reports|December 9, 2014
Capture-stabilize approach for membrane protein SPR assaysRuiyin Chu, David Reczek, William Brondyk
European Journal of Cell Biology|March 15, 2002
Distinct cell type-specific expression of scaffolding proteins EBP50 and E3KARP: EBP50 is generally expressed with ezrin in specific epithelia, whereas E3KARP is notJanet Ingraffea, David Reczek, Anthony Bretscher
The Journal of Cell Biology|December 6, 2006
EPI64 regulates microvillar subdomains and structureAbraham Hanono, Damien Garbett, David Reczek, et al.
Mabs|March 28, 2025
Rapid affinity-based purification of multi-specific antibodies using Kappa Select and Protein LKalie Mix, Tingwan Sun, Brian Hall, et al.
ACS Chemical Biology|December 14, 2006
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variantsAnu R Sawkar, Martina Schmitz, Klaus-Peter Zimmer, et al.
Cell|November 21, 2007
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidaseDavid Reczek, Michael Schwake, Jenny Schröder, et al.
Mabs|December 14, 2025
Targeted dual selection to optimize transposon stable pool generation of multispecificsJulie Johnston, Sonja Tierson, Yuyan Xu, et al.
The Journal of Clinical Investigation|September 4, 2003
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agentTheresa Berndt, Theodore A Craig, Ann E Bowe, et al.
Molecular Genetics and Metabolism|July 23, 2013
Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal miceNelson S Yew, Emmanuelle Dufour, Malgorzata Przybylska, et al.
Glycobiology|January 26, 2007
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher diseaseScott M Van Patten, Heather Hughes, Michael R Huff, et al.
Pageof 2